Skip to main content
Premium Trial:

Request an Annual Quote

Genstruct Closes $6.5 Million Financing Round

NEW YORK, Sept. 8 (GenomeWeb News) - Genstruct, a biological mechanism discovery company, said today that it has raised $6.5 million in a round of Series A financing.

Proceeds of the financing, the Cambridge, Mass.-based company said, will be used to expand its technical and business teams, build intellectual property around the company's enabling technology, and conduct internal discovery programs.

The financing was led by A. M. Pappas and Associates, which has placed managing partner Art Pappas on Genstruct's board, and Flagship Ventures.

The Scan

Study Links Genetic Risk for ADHD With Alzheimer's Disease

A higher polygenic risk score for attention-deficit/hyperactivity disorder is also linked to cognitive decline and Alzheimer's disease, a new study in Molecular Psychiatry finds.

Study Offers Insights Into Role of Structural Variants in Cancer

A new study in Nature using cell lines shows that structural variants can enable oncogene activation.

Computer Model Uses Genetics, Health Data to Predict Mental Disorders

A new model in JAMA Psychiatry finds combining genetic and health record data can predict a mental disorder diagnosis before one is made clinically.

Study Tracks Off-Target Gene Edits Linked to Epigenetic Features

Using machine learning, researchers characterize in BMC Genomics the potential off-target effects of 19 computed or experimentally determined epigenetic features during CRISPR-Cas9 editing.